NYU LANGONE HEALTH

NYU LANGONE HEALTH logo
🇺🇸United States
Ownership
Private
Established
1841-01-01
Employees
10K
Market Cap
-
Website
http://www.nyulangone.org

Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer

First Posted Date
2009-03-13
Last Posted Date
2016-06-30
Lead Sponsor
NYU Langone Health
Target Recruit Count
24
Registration Number
NCT00861471
Locations
🇺🇸

Bellevue Hospital, New York, New York, United States

🇺🇸

NYU Clinical Cancer Center, New York, New York, United States

🇺🇸

NYU Tisch Hospital, New York, New York, United States

Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer

Phase 2
Completed
Conditions
First Posted Date
2009-03-09
Last Posted Date
2016-03-11
Lead Sponsor
NYU Langone Health
Target Recruit Count
28
Registration Number
NCT00858338
Locations
🇺🇸

Bellevue Hospital, New York, New York, United States

🇺🇸

NYU Tisch Hospital, New York, New York, United States

🇺🇸

NYU Cancer Center, New York, New York, United States

Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer

First Posted Date
2009-03-06
Last Posted Date
2015-12-07
Lead Sponsor
NYU Langone Health
Target Recruit Count
30
Registration Number
NCT00857246
Locations
🇺🇸

NYU Cancer Center, New York, New York, United States

Postoperative Cognitive Decline, Inflammation, and Plasma Levels of Beta-amyloids

First Posted Date
2009-02-25
Last Posted Date
2016-03-17
Lead Sponsor
NYU Langone Health
Target Recruit Count
41
Registration Number
NCT00850928
Locations
🇺🇸

NYU School of Medicine, New York City, New York, United States

Cancer Screening and Prevention Program for High Risk Women

Completed
Conditions
First Posted Date
2009-02-23
Last Posted Date
2020-05-06
Lead Sponsor
NYU Langone Health
Target Recruit Count
1452
Registration Number
NCT00849199
Locations
🇺🇸

Bellevue Hospital, New York, New York, United States

🇺🇸

NYU Cancer Center, New York, New York, United States

🇺🇸

NYU Tisch Hospital, New York, New York, United States

Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers

First Posted Date
2009-02-20
Last Posted Date
2018-01-08
Lead Sponsor
NYU Langone Health
Target Recruit Count
8
Registration Number
NCT00848783
Locations
🇺🇸

Bellevue Hospital, New York, New York, United States

🇺🇸

NYU Cancer Center, New York, New York, United States

🇺🇸

Norris Cancer Center, Los Angeles, California, United States

Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-02-19
Last Posted Date
2019-09-30
Lead Sponsor
NYU Langone Health
Target Recruit Count
15
Registration Number
NCT00846612
Locations
🇺🇸

Bellevue Hospital, New York, New York, United States

🇺🇸

Univ. of New Mexico cancer research and treatment center, Albuquerque, New Mexico, United States

🇺🇸

NYU medical center (Tisch Hospital), New York, New York, United States

and more 1 locations

Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma

First Posted Date
2009-02-13
Last Posted Date
2017-07-19
Lead Sponsor
NYU Langone Health
Target Recruit Count
8
Registration Number
NCT00843310
Locations
🇺🇸

Bellevue Hospital, New York, New York, United States

🇺🇸

NYU Tisch Hospital, New York, New York, United States

🇺🇸

NYU Cancer Center, New York, New York, United States

Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2009-02-10
Last Posted Date
2012-11-19
Lead Sponsor
NYU Langone Health
Target Recruit Count
14
Registration Number
NCT00840450
Locations
🇺🇸

NYU cancer center, New York, New York, United States

Trial of a Multilevel Intervention to Increase Colorectal Cancer Screening

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2009-02-04
Last Posted Date
2009-02-04
Lead Sponsor
NYU Langone Health
Target Recruit Count
130
Registration Number
NCT00836303
Locations
🇺🇸

New York University School of Medicine, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath